ince bone morphogenetic proteins (BMPs) are highly homologous, we investigated the hypothesis that recombinant BMP-4 of the genome of Xenopus laevis (rxBMP-4) may influence the proliferation or differentiation of human primary osteoblast-like cells (HPOC), as occurs with recombinant human BMP (rhBMP-2).
Bone morphogenetic proteins (BMPs) are cytokines originally identified as factors extractable from bone 1 which induce the formation of ectopic bone at non-skeletal sites of implantation. [2] [3] [4] [5] After cloning the first four cDNAs, Wozney et al 6 demonstrated that with the exception of BMP-1, BMPs belong to the transforming growth factor-␤ (TGF-␤) superfamily. BMP-2 and BMP-4, previously BMP-2A and BMP-2B, are quite closely related and form one group 5, 7 within this superfamily. BMP-2 has been shown to induce bone formation de novo and bone repair in vivo. 8 In vitro experiments, using recombinant human BMP-2 (rhBMP-2) have been carried out to explore the effects of BMPs on the differentiation of osteoblasts and the formation of bone. [9] [10] [11] [12] A sequence analysis of the amino-acid composition of human BMP-4 and BMP-4 derived from Xenopus laevis (rxBMP-4) has revealed a close relationship between both proteins, especially in the mature part of the protein. 13 To the best of our knowledge, nothing is known about the physiological effects of rxBMP-4 on the process of differentiation and repair of human bones, but it is known to be an inducer of mesoderm formation during the early stage of development of the Xenopus embryo 13 and it provokes cell differentiation of the osteoblastic mouse cell line MC3T3-E1. 14 Because of the high conservation and the similarity of the protein, the question arose as to whether rxBMP-4 like rhBMP-2 is able to promote the differentiation of human osteoblasts. To test this hypothesis, we examined the effects of rxBMP-4, rhBMP-2 and recombinant human fibroblast growth factor (rh-bFGF). In contrast to BMPs, bFGF, which is also synthesised in osteoblasts, seems to be a bone-regulating factor since it enhances the proliferation of osteoblasts in vitro 15, 16 with an inhibitory effect on their differentiation. 17 
Materials and Methods
Cell culture. Cultures of osteoblasts were established according to the method described by Robey and Termine. 18 Fragments of cancellous bone were obtained during routine hip and knee replacements from four men and two women aged between 34 and 79 years. The fragments were dissected, minced, and rinsed several times with physiological saline solution to remove blood components. For collagenase digestion, the bone chips were incubated in serum-free Dulbecco's modification of Eagle's minimum essential medium (DMEM) containing 0.5% of crude collagenase (type IV; Sigma Chemical Company, St Louis, Missouri) at 37°C with rotation for two hours. The remaining collagenase-treated bone chips were washed once with serum-containing medium to inhibit collagenase and plated in six-well plates. The cells were incubated with DMEM culture medium which was depleted for Ca 2+ and supplemented with 10% (v/v) heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine, 100 U/ml of streptomycin/penicillin, 1.0% amphotericin B (all compounds from Biochrom KG, Berlin, Germany) and 0.08% certomycin 50 (Essex Pharma GmbH, München, Germany). The cell cultures were incubated at 37°C in 5% CO 2 and saturated humidity. The culture medium was changed twice a week. A confluent monolayer with primary human osteoblastlike cells was detected after about four to five weeks. Cells were subcultured by 0.05% (w/v) trypsin and 0.02% (w/v) EDTA. Experiments were performed only in one of the first three cell passages as well as in the stage of cell maturation.
This technique of cell isolation maintains the osteoblastic phenotype as deduced from the synthesis of osteocalcin and type-I procollagen, and von Kossa staining. 19, 20 Growth factors. The cells were stimulated by three different growth factors. rh-bFGF was purchased from TEBU GmbH (Frankfurt, Germany), rhBMP-2 was provided by the Theodor-Boveri Institute of the University of Würz-burg, Germany 21 and rxBMP-4 was produced in a bacterial expression system as follows. The mature part of the protein (rxBMP-4) fused to a His-tag was expressed in E. coli. The protein was purified by Ni 2+ -agarose-column chromatography and refolded by dialysis. The amount of the isolated rxBMP-4 was assayed on a Coomassie-stained polyacrylamide gel. Measurement of proliferation. Osteoblastic cells were plated at a density of 5000 cells/well in 96-well flatbottomed Nunclon microwell plates (Nunc, Roskilde, Denmark). The cells were grown in DMEM culture medium, composed as described above, but supplemented with 1.8 mM Ca 2+ . Cells were allowed to adhere for 24 hours.
Thereafter, serum-free DMEM culture medium, containing two different concentrations of the growth factors (50 ng/ ml and 100 ng/ml), was added and the plates were incubated for an additional 72 hours. The rates of proliferation were estimated by colorimetric MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. 22 The assay principle is based on a reduction of MTT (Sigma Chemical Co) by mitochondrial dehydrogenases of viable cells. The MTT reaction product, a blue formazan derivative, was measured photometrically at 550 nm. Ten microlitres of MTT stock solution (5 mg/ml) were added to each well and incubated at 37°C for four hours. The microwell plates were centrifuged at 4000 ϫ g for ten minutes and the supernatant was removed. Dimethylsulphoxide was added to each well to solubilise the formazan crystals. Afterwards, microtitre plates were placed on a plate shaker for five minutes and the absorbence was monitored at 550 nm using a microtitre plate reader. Measurement of cell differentiation. The extent of cell differentiation was judged from the increase in activity of the enzyme alkaline phosphatase (ALP). 23 Osteoblastic cells were plated at a density of 100 000 cells/well in 12-well Nunclon microwell plates (Nunc), stimulated by growth factors and cultured for 72 hours as described above. After washing the cells, a lysis buffer containing 0.1% (v/v) Triton X-100, 1mM MgCl 2 , 0.1 mM ZnCl 2 and 20 mM Tris (Merck KG, Darmstadt, Germany), pH 10, was added and the cells were frozen at -80°C and stored overnight. The activity of ALP was determined by a diagnostic kit according to the instructions of the supplier (Boehringer Mannheim GmbH, Mannheim, Germany). For each assay, 100 l of cell lysate were incubated with 1 ml of a p-nitrophenyl phosphate solution (10 mM). The activity of ALP was monitored photometrically (405 nm) by the production of p-nitrophenol. Identification of the osteoblastic phenotype. The detection of osteocalcin, type-1 procollagen and cell mineralisation was used to verify the phenotype of the cells. 19, 20 The amount of osteocalcin and type-1 procollagen secreted into the culture medium was measured photometrically using commercially available kits (Novocalcin and Prolagen-C; DPA Biermann GmbH, Bad Nauheim, Germany). Cell mineralisation of fixed cell layers was determined microscopically by a modified von Kossa staining technique.
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Statistical analysis. All measurements were performed at least in triplicate. Unless otherwise stated, the results are shown as the mean ± standard deviation (SD) expressed as the percentage of the control. Single-factor analysis of variance (ANOVA) was used to assess the statistical significance of data. Dunnet's method was used for multiple comparison tests. Differences in means were considered to be significant if p ≤ 0.05.
Results
The proliferation of human primary osteoblast-like cells (HPOC), derived from the bone material of six donors, differed with respect to the time period after which a state of confluence was attained. This was reached between three and six weeks after seeding of the bone fragments (mean 35 ± 6.3 days). Although the age of the donors varied considerably (mean 62.8 ± 21. After an incubation period of 72 hours the addition of rhbFGF (50 ng/ml and 100 ng/ml) induced a significant increase in the rate of proliferation of the cell cultures by about 50% (Fig. 1) . rhBMP-2 and rxBMP-4, however, had no effect.
The ALP activity of untreated cells was 7.2 ± 0.7 U/ml. As shown in Figure 2 , both BMPs provoked cell differentiation as judged by the increase in ALP activity by almost the same extent (78%) compared with untreated cells. No difference in efficacy was observed between human BMP and Xenopus BMP (Fig. 2) . The addition of rh-bFGF had no effect on cell differentiation (Fig. 2) .
Discussion
Our findings showed that rh-bFGF stimulated the proliferation of HPOC but failed to provoke cell differentiation. By contrast, rhBMP-2 and rxBMP-4 did not affect cell proliferation but induced a differentiation of HPOC to almost the same extent. These findings are based on two independent parameters, namely the rate of proliferation and the activity of ALP, which is a well-accepted marker of osteogenesis in these cultures. 23 This suggests that either the cells seem to have receptors for BMP-2 and BMP-4 or that both BMPs bind with almost the same affinity to the same receptor. This observation agrees with the results of radioligand binding assays published by Yamaji et al. 25 They showed that rhBMP-2 and rhBMP-4 bind with similar affinities to the same CFK-43a protein, which was thought to be a serine/threonine kinase receptor of rhBMP-2 and rhBMP-4. This assumption was confirmed by several authors who showed that rhBMP-2 and rhBMP-4 bind to the same receptor type classified as BMPR-II. 26 According to our data, rxBMP-4 was as equally effective as rhBMP-2, suggesting that human BMP-4 and Xenopus BMP-4 bind to the same receptor, which is presumably BMPR-II. This idea is consistent with the high degree of amino-acid homology (86% in the mature part of the protein) observed for rhBMP-4 and rhBMP-2. rxBMP-4 failed to stimulate proliferation of HPOC and behaved like rhBMP-2. To exclude a false-negative result, rh-bFGF was used as a positive control to stimulate cell proliferation. 15, 16 As expected, 50 to 100 ng/ml of rh-bFGF enhanced cell proliferation by about 80% of the control value. This result is consistent with previous studies which showed an antagonistic interaction between the signalling system of FGF and BMP in a model of limb outgrowth. Niswander and Martin 27 proved that FGF-4 stimulated proliferation of mesenchyme in the early mouse limb bud, whereas rhBMP-2 inhibited limb growth. Zheng et al 28 reported, however, that rhBMP-2 stimulated cell proliferation in a human osteoblast-like cell line (HOB1T). This discrepancy in the action of rxBMP-4 on HOB1T and HPOC may be due to the difference in origin of both cell types. Zheng et al 28 used a permanent cell line established by transfection with SV40 large T antigen, whereas we used primary human osteoblast-like cells. Considering the concentration dependency of the BMP action, we have shown that in our in vitro model HPOC differentiation was already induced at a concentration of BMP of 50 to 100 ng/ml. This effective range of concentration corresponds to data published by Hughes et al. 29 They induced the formation of bone nodules by rhBMP-2 and rhBMP-4 which were maximally effective in a range of 25 to 50 ng/ml of BMP. Similar results were obtained by Mean (±SD) specific activity of the MTT assay (%/control) for rhBMP-2, rxBMP-4 (50 and 100 ng/ml) and rh-bFGF (see text). Mean (±SD) specific activity for ALP for rhBMP-2, rxBMP-4 (50 and 100 ng/ml) and rh-bFGF (see text).
